STIMULATION OF FIBRINOGEN SYNTHESIS BY THROMBIN IN RABBITS WITH ANCROD-INDUCED AFIBRINOGENEMIA.ALVING BM; EVATT BL; BELL WR et al.1977; AMER. J. PHYSIOL., HEART CIRCUL. PHYSIOL.; U.S.A.; DA. 1977; VOL. 2; NO 5; PP. 562-567; BIBL. 28 REF.Article

Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritisCUNNINGHAM, Malcolm A; KITCHING, A. Richard; TIPPING, Peter G et al.Kidney international. 2004, Vol 66, Num 2, pp 647-654, issn 0085-2538, 8 p.Article

Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletionPALMQVIST, Niklas; JOSEFSSON, Elisabet; TARKOWSKI, Andrzej et al.Microbes and infection. 2004, Vol 6, Num 2, pp 196-201, issn 1286-4579, 6 p.Article

THE DEGRADATION OF SOLUBLE VERSUS INSOLUBLE FIBRIN IN VIVO = LA DEGRADATION DE LA FIBRINE SOLUBLE EN FIBRINE INSOLUBLE IN VIVOLIPINSKI B; GUREWICH V.1976; THROMBOSIS RES.; G.B.; DA. 1976; VOL. 8; NO 1; PP. 119-120; BIBL. 7 REF.Article

Anticoagulant therapy with ancrodSOUTAR, R. L; GINSBERG, J. S.Critical reviews in oncology/hematology. 1993, Vol 15, Num 1, pp 23-33, issn 1040-8428Article

Ancrod causes rapid thrombolysis in patients with acute strokePOLLAK, V. E; GLAS-GREENWALT, P; OLINGER, C. P et al.The American journal of the medical sciences. 1990, Vol 299, Num 5, pp 319-325, issn 0002-9629Article

EFFECT OF DEFIBRINOGENATION ON WOUND STRENGTH AND COLLAGEN FORMATIONBRAENDSTEDT S; OLSON PS.1980; ACTA CHIR. SCAND.; ISSN 0001-5482; SWE; DA. 1980; VOL. 146; NO 7; PP. 483-486; BIBL. 26 REF.Article

THE ACTIVATION OF PLASMA FACTOR XIII WITH THE SNAKE VENOM ENZYMES ANCROD AND BATROXOBIN MARAJOENSIS.WALTER M; NYMAN D; KRAJNC V et al.1977; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1977; VOL. 38; NO 2; PP. 438-446; ABS. FR. ALLEM.; BIBL. 16 REF.Article

Plasminogen activation without changes in tPA and PAI-1 in response to subcutaneous administration of ancrodDEMPFLE, Carl-Erik; ALESCI, Sonja; KUCHER, Klaus et al.Thrombosis research. 2001, Vol 104, Num 6, pp 433-438, issn 0049-3848Article

The cleavage and inactivation of plasminogen activator inhibitor type 1 and α2-antiplasmin by reptilase, a thrombin-like venom enzymeURANO, T; IHARA, H; TAKADA, Y et al.Blood coagulation & fibrinolysis. 2000, Vol 11, Num 2, pp 145-153, issn 0957-5235Article

Analysis of fibrin formation and proteolysis during intravenous administration of ancrodDEMPFLE, Carl-Erik; ARGIRIOU, Sotiria; KUCHER, Klaus et al.Blood. 2000, Vol 96, Num 8, pp 2793-2802, issn 0006-4971Article

Heparinless cardiopulmonary bypass with ancrodO-YURVATI, A. H; LAUB, G. W; SOUTHGATE, T. J et al.The Annals of thoracic surgery. 1994, Vol 57, Num 6, pp 1656-1658, issn 0003-4975Article

Ancrod for coronary angioplastyPOTHOULAKIS, A. J; NEERUKONDA, S. K; ANSEL, G et al.Texas Heart Institute journal. 1995, Vol 22, Num 4, pp 342-346, issn 0730-2347Article

Ancrod: a practical alternative to heparinCOLE, C. W; BORMANIS, J.Journal of vascular surgery. 1988, Vol 8, Num 1, pp 59-63, issn 0741-5214Article

Diffuse proliferative lupus nephritis : long-term observations in patients treated with ancrodHARIHARAN, S; POLLAK, V. E; KANT, K. S et al.Clinical nephrology. 1990, Vol 34, Num 2, pp 61-69, issn 0301-0430, 9 p.Article

DEFIBRINIERUNG IN DER ULCUSTHERAPIE BER DIABETISCHER MIKROANGIOPATHIE = TRAITEMENT DES ULCERES DE JAMBE DE LA MICROANGIOPATHIE DIABETIQUE PAR DEFIBRINATIONHOTING E; WASSILEW S.1983; H+G. ZEITSCHRIFT FUER HAUTKRANKHEITEN; ISSN 0301-0481; DEU; DA. 1983; VOL. 58; NO 3; PP. 181-184; ABS. ENG; BIBL. 6 REF.Article

Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial : a randomised controlled trial. CommentaryKASTE, Markku; HENNERICI, Michael G; KAY, Richard et al.Lancet (British edition). 2006, Vol 368, Num 9550, issn 0140-6736, 1845-1846,1871-1878 [10 p.]Article

Ancrod in the treatment of acute ischaemic stroke. DiscussionATKINSON, R. P; BELL, W. R.Drugs (Basel). 1997, Vol 54, pp 100-108, issn 0012-6667, SUP3Conference Paper

Defibrinogenating enzymes. DiscussionBELL, W. R; MARKLAND, F. S.Drugs (Basel). 1997, Vol 54, pp 18-31, issn 0012-6667, SUP3Conference Paper

Amino acid sequence determination of ancrod, the thrombin-like α-fibrinogenase from the venom of Akistrodon rhodostomaBURKHART, W; SMITH, G. F. H; SU, J.-L et al.FEBS letters. 1992, Vol 297, Num 3, pp 297-301, issn 0014-5793Article

Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodSHASHI KANT, K; POLLAK, V. E; AKINSANSOYE DOSEKUN et al.The Journal of laboratory and clinical medicine. 1985, Vol 105, Num 1, pp 77-88, issn 0022-2143Article

Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritisGLAS-GREENWALT, P; SHASHI KANT, K; AKINSANSOYE DOSEKUN et al.The Journal of laboratory and clinical medicine. 1985, Vol 105, Num 1, pp 99-107, issn 0022-2143Article

Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathyRINGELSTEIN, E. B; MAUCKNER, A; ESCHENFELDER, V et al.Journal of neurology, neurosurgery and psychiatry. 1988, Vol 51, Num 8, pp 1051-1057, issn 0022-3050Article

The antiplatelet activity of ancrod on administration to rabbitsMEI-CHI CHANG; TUR-FU HUANG.The Journal of laboratory and clinical medicine. 1995, Vol 125, Num 4, pp 508-516, issn 0022-2143Article

Ancrod prevents vascular occlusion in thermally injured ratsEHRLICH, H. P; MCGRANE, W. L; RAJARATNAM, J. B. M et al.The Journal of trauma. 1987, Vol 27, Num 4, pp 420-424, issn 0022-5282Article